SL
IDXX icon

Salomon & Ludwin’s Idexx Laboratories IDXX Stock Holding History

Salomon & Ludwin’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Buy
47
+24
+104% +$13.5K ﹤0.01% 980
2026
Q1 		$13.1K Sell
23
-28
-55% -$18K ﹤0.01% 1375
2025
Q4 		$34.8K Sell
51
-4
-7% -$2.72K ﹤0.01% 542
2025
Q3 		$34.7K Buy
+55
New +$33.4K ﹤0.01% 505

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Salomon & Ludwin's IDXX Position: Q2 2026 in Review

Salomon & Ludwin increased its Idexx Laboratories (IDXX) stake by 104% in Q2 2026, buying an estimated $13.5K and bringing the position to 47 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Salomon & Ludwin first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $34.8K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Salomon & Ludwin held 47 shares of Idexx Laboratories worth $25.3K as of Q2 2026.
  • Salomon & Ludwin bought 24 Idexx Laboratories shares in Q2 2026, an estimated $13.5K.
  • Idexx Laboratories made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #980 holding.
  • Salomon & Ludwin first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Idexx Laboratories position peaked at $34.8K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.